Summary Literature (3)

DOID:0080208 - metabolic dysfunction-associated steatotic liver disease

Disease Ontology Definition:A steatotic liver disease characterized by at least one of five specified cardiometabolic risk factors and no other discernible cause with normal to no alcohol use. The five cardiometabolic risk factors are: (1) higher than normal body mass index or waist circumference; (2) higher than normal serum glucose or glycated hemoglobin level, or type 2 diabetes; (3) higher than normal blood pressure or hypertensive treatment; (4) higher than normal plasma triglycerides or lipid lowering treatment; and (5) lower than normal plasma high-density lipoprotein cholesterol.

Synonyms: non-alcoholic fatty liver disease, NAFLD, MAFLD, MASLD, metabolic dysfunction-associated fatty liver disease, metabolic dysfunction-related steatotic liver disease, metabolic-associated fatty liver disease, nonalcoholic fatty liver disease, NAFL, non-alcoholic fatty liver, nonalcoholic fatty liver

Xenbase Genes :

Mondo Disease Ontology (on Monarch Initiative):

MONDO:0013209 - metabolic dysfunction-associated steatotic liver disease

MIM:

MIM:613282 - FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 1; FLD1

MIM:613387 - FATTY LIVER DISEASE, SUSCEPTIBILITY TO, 2; FLD2

Other Model Organisms: Alliance, MGI, ZFIN, FlyBase, WormBase, RGD

Ontology Viewers: Disease Ontology, EMBL-EBI, OLSVis tree view, Ontobee